SEMplMe: a tool for integrating DNA methylation effects in transcription factor binding affinity predictions

BMC Bioinformatics. 2022 Aug 4;23(1):317. doi: 10.1186/s12859-022-04865-x.

Abstract

Motivation: Aberrant DNA methylation in transcription factor binding sites has been shown to lead to anomalous gene regulation that is strongly associated with human disease. However, the majority of methylation-sensitive positions within transcription factor binding sites remain unknown. Here we introduce SEMplMe, a computational tool to generate predictions of the effect of methylation on transcription factor binding strength in every position within a transcription factor's motif.

Results: SEMplMe uses ChIP-seq and whole genome bisulfite sequencing to predict effects of methylation within binding sites. SEMplMe validates known methylation sensitive and insensitive positions within a binding motif, identifies cell type specific transcription factor binding driven by methylation, and outperforms SELEX-based predictions for CTCF. These predictions can be used to identify aberrant sites of DNA methylation contributing to human disease.

Availability and implementation: SEMplMe is available from https://github.com/Boyle-Lab/SEMplMe .

Keywords: DNA methylation; Gene regulation; Noncoding variation; Open-source; Software; TFBS; Transcription factor.

MeSH terms

  • Binding Sites
  • DNA Methylation*
  • Gene Expression Regulation
  • Humans
  • Protein Binding
  • Transcription Factors* / metabolism

Substances

  • Transcription Factors